Tue, June 18, 2024

Andrew Fein Maintained (ZNTL) at Strong Buy with Decreased Target to $20 on, Jun 18th, 2024

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-20-on-jun-18th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Andrew Fein of HC Wainwright & Co., Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy with Decreased Target from $40 to $20 on, Jun 18th, 2024.

Andrew has made no other calls on ZNTL in the last 4 months.



There is 1 other peer that has a rating on ZNTL. Out of the 1 peers that are also analyzing ZNTL, all agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Robert Driscoll of "Wedbush" Maintained at Hold with Increased Target to $15 on, Wednesday, February 28th, 2024